Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Telix Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$8.87B | 177.8x | 0.23 | A$26.86 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.3% Upside | Upgrade to Pro+ | |
Mesoblast | Sydney | Healthcare | Biotechnology & Medical Research | A$2.63B | -14x | 2.28 | A$2.06 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.8% Upside | Upgrade to Pro+ | |
Clarity Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$867.65M | -19.5x | 0.5 | A$2.63 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Opthea | Sydney | Healthcare | Biotechnology & Medical Research | A$751.08M | -1.5x | -0.11 | A$0.61 | -6.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PYC Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$575.33M | -11.2x | 0.15 | A$1.23 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immutep | Sydney | Healthcare | Biotechnology & Medical Research | A$407.57M | -8.5x | -0.63 | A$0.28 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CogState Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$232.95M | 19.8x | 0.49 | A$1.36 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.2% Upside | Upgrade to Pro+ | |
Imugene Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$231.18M | -1.8x | 0.07 | A$0.03 | -8.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dimerix | Sydney | Healthcare | Biotechnology & Medical Research | A$223.34M | -9.1x | 0.2 | A$0.41 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Race Oncology | Sydney | Healthcare | Biotechnology & Medical Research | A$172.85M | -22.2x | -0.7 | A$1 | -5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Paradigm Biopharmaceuticals Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$163.56M | -9.6x | -0.15 | A$0.42 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arovella Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$97.90M | -15.3x | -0.35 | A$0.09 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pacific Edge | Sydney | Healthcare | Biotechnology & Medical Research | A$95.73M | -3.7x | -0.37 | A$0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LTR Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$95.01M | -11.7x | 0.05 | A$0.52 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Argenica Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$94.15M | -17.6x | -0.81 | A$0.76 | 3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Actinogen Medical | Sydney | Healthcare | Biotechnology & Medical Research | A$90.85M | -7.3x | -0.19 | A$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avita Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$72.22M | -0.7x | 0.05 | A$2.73 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Proteomics Intl Labs | Sydney | Healthcare | Biotechnology & Medical Research | A$63.54M | -9.6x | -3.59 | A$0.49 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2% Upside | Upgrade to Pro+ | |
Alterity Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$49.42M | -2.3x | -0.13 | A$0.009 | -10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioxyne Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$49.18M | 24x | 0.21 | A$0.02 | 9.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cynata Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$48.43M | -4.4x | -0.14 | A$0.22 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tryptamine Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$45.95M | -2.4x | -0.45 | A$0.04 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IDT Australia Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$45.13M | -8.8x | -0.2 | A$0.10 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anteo Diagnostics | Sydney | Healthcare | Biotechnology & Medical Research | A$37.87M | -3.5x | -0.12 | A$0.01 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prescient Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$33.02M | -4.8x | -0.45 | A$0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Island Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$31.74M | -6.2x | -1.12 | A$0.19 | 12.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurotech Intl | Sydney | Healthcare | Biotechnology & Medical Research | A$30.22M | -2.4x | 0.03 | A$0.03 | -9.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amplia Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$26.38M | -2.4x | 0.22 | A$0.07 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhythm Biosciences | Sydney | Healthcare | Biotechnology & Medical Research | A$24.11M | -9.4x | -0.15 | A$0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clever Culture Systems | Sydney | Healthcare | Biotechnology & Medical Research | A$22.96M | -13x | -0.31 | A$0.01 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Noxopharm | Sydney | Healthcare | Biotechnology & Medical Research | A$22.79M | -9.9x | -0.11 | A$0.08 | 8.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avecho Bio | Sydney | Healthcare | Biotechnology & Medical Research | A$19.02M | -6x | -0.18 | A$0.006 | -21.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BTC Health | Sydney | Healthcare | Biotechnology & Medical Research | A$16.53M | 3.9x | 0.03 | A$0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tissue Repair | Sydney | Healthcare | Biotechnology & Medical Research | A$16.33M | -3.7x | 0.1 | A$0.27 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Emyria | Sydney | Healthcare | Biotechnology & Medical Research | A$15.20M | -8.2x | -0.09 | A$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BPH Energy Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$12.18M | 0.9x | 0 | A$0.010 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Percheron Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$10.87M | -0.7x | 0.37 | A$0.010 | -9.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Algorae Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$8.44M | -5x | -0.14 | A$0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Invion Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$8.12M | -1x | 0.01 | A$0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Chimeric Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$7.88M | -0.3x | -0.05 | A$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Holista CollTech Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$7.14M | -100x | -1.04 | A$0.03 | -7.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adalta | Sydney | Healthcare | Biotechnology & Medical Research | A$6.31M | -1.1x | -0.04 | A$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zelira Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$5.67M | -1.2x | -0.01 | A$0.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neuroscientific Biopharma | Sydney | Healthcare | Biotechnology & Medical Research | A$5.21M | 4.5x | 0.08 | A$0.04 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cambium Bio | Sydney | Healthcare | Biotechnology & Medical Research | A$4.65M | -390x | A$0.35 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Invex Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$4.51M | 49.6x | 0.39 | A$0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Patrys Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$4.11M | -1x | -0.03 | A$0.002 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vectus Biosystems | Sydney | Healthcare | Biotechnology & Medical Research | A$3.99M | -1.8x | -0.2 | A$0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biotron Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$2.71M | -1.5x | -0.04 | A$0.003 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hexima | Sydney | Healthcare | Biotechnology & Medical Research | A$2.17M | -2.3x | 0.07 | A$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |